Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time

被引:31
作者
Bianchi, Marco [1 ,2 ]
Becker, Andreas [1 ,3 ]
Hansen, Jens [3 ]
Quoc-Dien Trinh [1 ,4 ]
Tian, Zhe [1 ]
Abdollah, Firas [2 ]
Briganti, Alberto [2 ]
Shariat, Shahrokh F. [5 ]
Perrotte, Paul [6 ]
Montorsi, Francesco [2 ]
Karakiewicz, Pierre I. [1 ,6 ]
Sun, Maxine [1 ]
机构
[1] Univ Montreal, Ctr Hlth, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ H2X 3J4, Canada
[2] Univ Vita Salute San Raffaele, Dept Urol, Milan, Italy
[3] Prostate Canc Ctr Hamburg Eppendorf, Martini Clin, Hamburg, Germany
[4] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Surg,Div Urol,Med Sch, Boston, MA 02115 USA
[5] Cornell Univ, Weill Med Coll, Dept Urol, New York, NY 10021 USA
[6] Univ Montreal, Ctr Hlth, Dept Urol, Montreal, PQ H2X 3J4, Canada
关键词
renal cell carcinoma; RCC; conditional survival; nephrectomy; CANCER;
D O I
10.1111/bju.12115
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To examine the impact of length of survival on future survival probability, otherwise known as the effect of conditional survival (CS), after nephrectomy (NT) in patients diagnosed with renal cell carcinoma (RCC). Patients and Methods Overall, 42090 patients with RCC who underwent NT were abstracted from the Surveillance, Epidemiology, and End Results database (1988-2008). Based on cumulative survival estimates, CS rates were derived according to patient and disease characteristics. Separate multivariable Cox regression analyses were performed for the prediction of cancer-specific mortality (CSM), according to 1-, 2-, 3-, 4- and 5-year survival postoperatively. Results Immediately after surgery, the 5-year cancer-specific survival rate was 83.5%. Amongst patients who survived 1, 2, 3, 4, and 5 years after NT, the probability rates for surviving an additional 5 years were 87.0, 89.6, 90.9, 92.0 and 92.3%, respectively. Provided that patients survived 1 and 2 years after NT, the probability of being CSM-free for another 5 years increased by +4.1 and 4.3% for stage III and +12.9 and 10.3% for stage IV disease, respectively. Similar observations were recorded for patient age, grade, nodal stage and tumour size, and were confirmed upon multivariable analyses. Conclusion Survival probabilities vary according to length of survival after NT. Specifically, even amongst patients with more advanced disease at surgery, a more favourable prognosis can be achieved after surviving for 1-2 years.
引用
收藏
页码:E283 / E289
页数:7
相关论文
共 16 条
[1]   Conditional Relative Survival of Cancer Patients and Conditional Probability of Death [J].
Bouvier, Anne-Marie ;
Remontet, Laurent ;
Hedelin, Guy ;
Launoy, Guy ;
Jooste, Valerie ;
Grosclaude, Pascale ;
Belot, Aurelien ;
Lacour, Brigitte ;
Esteve, Jacques ;
Bossard, Nadine ;
Faivre, Jean .
CANCER, 2009, 115 (19) :4616-4624
[2]   Conditional Survival Estimates Improve Over 5 Years for Melanoma Survivors with Node-Positive Disease [J].
Bowles, Tawnya L. ;
Xing, Yan ;
Hu, Chung-Yuan ;
Mungovan, Kristi S. ;
Askew, Robert L. ;
Chang, George J. ;
Gershenwald, Jeffrey E. ;
Lee, Jeffrey E. ;
Mansfield, Paul F. ;
Ross, Merrick I. ;
Cormier, Janice N. .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (08) :2015-2023
[3]   Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma [J].
Capitanio, Umberto ;
Jeldres, Claudio ;
Patard, Jean-Jacques ;
Perrotte, Paul ;
Zini, Laurent ;
de La Taille, Alexandre ;
Ficarra, Vincenzo ;
Cindolo, Luca ;
Bensalah, Karim ;
Artibani, Walter ;
Tostain, Jacques ;
Valeri, Antoine ;
Zigeuner, Richard ;
Mejean, Arnaud ;
Descotes, Jean Luc ;
Lechevallier, Eric ;
Mulders, Peter F. ;
Lang, Herve ;
Jacqmin, Didier ;
Karakiewicz, Pierre I. .
BJU INTERNATIONAL, 2009, 103 (01) :33-37
[4]  
Howlader N., 2011, SEER cancer statistics review, 1975-2008
[5]   Conditional Survival Predictions After Nephrectomy for Renal Cell Carcinoma [J].
Karakiewicz, Pierre I. ;
Suardi, Nazareno ;
Capitanio, Umberto ;
Isbarn, Hendrik ;
Jeldres, Claudio ;
Perrotte, Paul ;
Sun, Maxine ;
Ficarra, Vincenzo ;
Zigeuner, Richard ;
Tostain, Jacques ;
Mejean, Arnaud ;
Cindolo, Luca ;
Pantuck, Allan J. ;
Belldegrun, Arie S. ;
Zini, Laurent ;
de la Taille, Alexandre ;
Chautard, Denis ;
Descotes, Jean-Luc ;
Shariat, Shahrokh F. ;
Valeri, Antoine ;
Mulders, Peter F. A. ;
Lang, Herve ;
Lechevallier, Eric ;
Patard, Jean-Jacques .
JOURNAL OF UROLOGY, 2009, 182 (06) :2607-2612
[6]   Clinical Calculator of Conditional Survival Estimates for Resected and Unresected Survivors of Pancreatic Cancer [J].
Katz, Matthew H. G. ;
Hu, Chung-Yuan ;
Fleming, Jason B. ;
Pisters, Peter W. T. ;
Lee, Jeffrey E. ;
Chang, George J. .
ARCHIVES OF SURGERY, 2012, 147 (06) :513-519
[7]   Evaluating Overall Survival and Competing Risks of Death in Patients With Localized Renal Cell Carcinoma Using a Comprehensive Nomogram [J].
Kutikov, Alexander ;
Egleston, Brian L. ;
Wong, Yu-Ning ;
Uzzo, Robert G. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) :311-317
[8]   Conditional Probability of Survival in Patients With Newly Diagnosed Glioblastoma [J].
Polley, Mei-Yin C. ;
Lamborn, Kathleen R. ;
Chang, Susan M. ;
Butowski, Nicholas ;
Clarke, Jennifer L. ;
Prados, Michael .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (31) :4175-4180
[9]   Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort [J].
Quoc-Dien Trinh ;
Schmitges, Jan ;
Bianchi, Marco ;
Sun, Maxine ;
Shariat, Shahrokh F. ;
Sammon, Jesse ;
Jeldres, Claudio ;
Zorn, Kevin ;
Sukumar, Shyam ;
Perrotte, Paul ;
Graefen, Markus ;
Rogers, Craig G. ;
Peabody, James O. ;
Menon, Mani ;
Karakiewicz, Pierre I. .
BJU INTERNATIONAL, 2012, 110 (2B) :E21-E27
[10]   Cancer Statistics, 2012 [J].
Siegel, Rebecca ;
Naishadham, Deepa ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2012, 62 (01) :10-29